Remedica

Remedica is a well-established, privately-held pharmaceutical company with a 40+ year history as a global generics powerhouse. Operating from its base in Cyprus, it leverages a robust manufacturing infrastructure and a broad therapeutic portfolio to serve diverse markets across Europe, Asia, the Middle East, Africa, and Latin America. The company's strategy is built on three pillars: fostering B2B partnerships, commercializing its own branded products in select regions, and maintaining strategic supply agreements with global humanitarian organizations like UNICEF and the WHO. Recent leadership changes and strategic partnerships signal a focus on continued global expansion and operational excellence.

Advanced pharmaceutical manufacturing with a focus on automation, robotics, and integrated quality control systems for the production of generic and OTC drugs.

Operates in the highly fragmented and competitive global generics market, competing against large multinational generics firms (e.g., Teva, Sandoz, Viatris) as well as regional and local manufacturers. Differentiation is achieved through a broad portfolio, cost-efficient automated manufacturing, strong NGO partnerships, and a direct commercial presence in key emerging regions.